TITLE

Fenugreek For Blood Sugar and Weight Loss Management

AUTHOR(S)
Mathern, Jocey
PUB. DATE
October 2003
SOURCE
Total Health;Oct/Nov2003, Vol. 25 Issue 5, 'Special section' p13
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Evaluates the health benefits of Fenugreek for blood sugar control and weight loss management. Mechanism of action of FenuLife, a fenugreek extract; Comparison of the therapeutic effect of psyllium husk powder concentration and fenugreek extract; Physiologic effects of fenugreek.
ACCESSION #
11567247

 

Related Articles

  • Screening of Crude Plant Extracts with Anti-Obesity Activity. Changhyun Roh; Uhee Jung // International Journal of Molecular Sciences;Feb2012, Vol. 13 Issue 2, p1710 

    Obesity is a global health problem. It is also known to be a risk factor for the development of metabolic disorders, type 2 diabetes, systemic hypertension, cardiovascular disease, dyslipidemia, and atherosclerosis. In this study, we screened crude extracts from 400 plants to test their...

  • Immunologic impact of the intestine in metabolic disease. Winer, Daniel A.; Winer, Shawn; Dranse, Helen J.; Lam, Tony K. T. // Journal of Clinical Investigation;Jan2017, Vol. 127 Issue 1, p33 

    Obesity and diabetes are associated with increased chronic low-grade inflammation and elevated plasma glucose levels. Although inflammation in the fat and liver are established features of obesity-associated insulin resistance, the intestine is emerging as a new site for immunologic changes that...

  • OBESITY TREATMENTS. Haslam, David // Pulse;10/31/2007, Vol. 67 Issue 39, p40 

    The author discusses several information on treatments for obesity. The author talks about the therapeutics that can be applied in alleviating corpulence. He includes the historical background for obesity treatment including mercury, arsenic, and strychnine. At the same time, he also cites the...

  • Mechanisms of Weight Loss After Bariatric Surgery. Flancbaum, Louis // Journal of Laparoendoscopic & Advanced Surgical Techniques;Aug2003, Vol. 13 Issue 4, p215 

    The surgical treatment of clinically severe obesity is becoming more popular. To date, little has been published concerning the mechanisms by which each of the commonly employed bariatric surgical procedures induces weight loss. This article reviews the physiology of weight loss induced by...

  • Management: Part II--Drugs. Lean, Mike; Finer, Nick // BMJ: British Medical Journal (International Edition);10/14/2006, Vol. 331 Issue 7572, p794 

    The article offers a look at drug treatment for obesity. Although diet and exercise play the most important role in weight loss, effective drugs against obesity should reduce energy assimilation from food or stimulate energy expenditure. The article discusses weight loss, weight maintenance,...

  • METFORMIN FOR WEIGHT LOSS.  // Life Extension;Sep2004, Vol. 10 Issue 9, p32 

    Points out that while metformin is used to treat diabetes, published research shows that it also helps non-diabetics to lose weight. Ability of metformin to reduce sugar release from liver to prevent blood glucose levels from rising too high, so that the body does not need to produce as much...

  • Weight control breakthrough? Investor's Business Daily // Investors Business Daily;12/16/2014, pA02 

    A new treatment for obesity and associated adult-onset diabetes essentially cured lab animals, Ind. Univ. researchers said. In preclinical trials, a peptide — a combination of 3 gastrointestinal hormones — lowered blood sugar levels and reduced body fat beyond all existing drugs,...

  • Relationships between glucose, energy intake and dietary composition in obese adults with type 2 diabetes receiving the cannabinoid 1 (CB1) receptor antagonist, rimonabant. Heppenstall, Charlotte; Bunce, Susan; Smith, Jamie C // Nutrition Journal;2012, Vol. 11, p50 

    Background: Weight loss is often difficult to achieve in individuals with type 2 diabetes and anti-obesity drugs are often advocated to support dietary intervention. Despite the extensive use of centrally acting anti-obesity drugs, there is little evidence of how they affect dietary composition....

  • Obesity market looks to new drugs for boost.  // Drug Store News;1/19/2009, Vol. 31 Issue 1, p26 

    The article reports on the increase in prescriptions and sales of drugs to treat obesity and related diseases in the U.S. According to a data from IMS Health Inc., prescriptions for the generic hypertension drug lininopril went from 42.4 million in 2003 to 70.5 million in 2007. On the other...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics